Results for the Fourth Quarter 2023

Currency neutral sales of own products was down 17.4 % for the quarter and down 5.1 % for the year. Download the full report and presentation, and watch the video recording from the webinar below.…

Read more

Results for the Third Quarter 2023

Currency neutral sales of own products was down 5.6% for the quarter and up 1.2% YTD September. Operating profit (EBIT) for the quarter ended at MNOK 34 giving a 27.0% EBIT margin (MNOK 34, a…

Read more

Presentation of Medistim’s Q2 2023 Financial Results

The financials will be presented via a live webinar on Thursday, August 31st from 08:00-09:00 (CEST). Representatives for the company will be Kari Eian Krogstad (CEO), and Thomas Jakobsen (CFO). The recording will be made available on…

Read more

Presentation of Medistim’s Q1 2023 Financial Results

The financials will be presented via a live webinar on Tuesday, April 25th from 08:00-09:00 (CEST). Representatives for the company will be Kari Eian Krogstad (CEO), and Thomas Jakobsen (CFO). The recording will be made available on…

Read more

Capital Markets Day

See the recording from Medistim's Capital Markets Day on March 21st where two international thought leaders, Professors John. D. Puskas and Pirkka Vikatmaa shared their insights on the future trends in Cardiac and Vascular Surgery…

Read more